ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 690,95
1,22%
DAX
18 001,60
0,54%
Brent Oil
82,81
-0,98%
Bitcoin
61 844,66
4,61%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Elite Pharmaceuticals, (ELI)

  7. Elite Pharmaceuticals, (ELI) Actualités

ELI

Elite Pharmaceuticals (ELI)

Elite Pharmaceuticals,
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:ELI
DateHeureSourceTitreSymboleSociété
11/05/200918h56Edgar (US Regulatory)-National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25)AMEX:ELIElite Pharmaceuticals,
06/05/200919h20Edgar (US Regulatory)Current report filing (8-K)AMEX:ELIElite Pharmaceuticals,
21/04/200922h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ELIElite Pharmaceuticals,
14/04/200923h28Edgar (US Regulatory)Amended Current report filing (8-K/A)AMEX:ELIElite Pharmaceuticals,
23/03/200916h39Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ELIElite Pharmaceuticals,
06/03/200921h48Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)AMEX:ELIElite Pharmaceuticals,
17/02/200922h33Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:ELIElite Pharmaceuticals,
17/02/200913h37Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)AMEX:ELIElite Pharmaceuticals,
16/01/200923h23Edgar (US Regulatory)Amended Annual Report (10-K/A)AMEX:ELIElite Pharmaceuticals,
21/11/200821h45Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)AMEX:ELIElite Pharmaceuticals,
20/11/200812h08Edgar (US Regulatory)Proxy Soliciting Materials (revised) (PRER14A)AMEX:ELIElite Pharmaceuticals,
13/11/200823h31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)AMEX:ELIElite Pharmaceuticals,
01/10/200822h25Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Current report filing (8-K)AMEX:ELIElite Pharmaceuticals,
29/09/200818h14MarketwiredAnalyst Reports for Mad Catz Interactive Inc., Elite Pharmaceuticals Inc., Peace Arch Entertainment Group Inc. and Evergreen IncAMEX:ELIElite Pharmaceuticals,
12/08/200818h35Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Quarterly Report (10-Q)AMEX:ELIElite Pharmaceuticals,
25/07/200820h06Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Statement of Changes in Beneficial Ownership (4)AMEX:ELIElite Pharmaceuticals,
27/06/200822h42Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Annual Report (10-K)AMEX:ELIElite Pharmaceuticals,
03/06/200820h36Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Amended Statement of Ownership (SC 13G/A)AMEX:ELIElite Pharmaceuticals,
27/05/200818h55Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Proxy Statement (definitive) (DEF 14A)AMEX:ELIElite Pharmaceuticals,
21/05/200821h22Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Proxy Soliciting Materials (revised) (PRER14A)AMEX:ELIElite Pharmaceuticals,
15/05/200821h53Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)AMEX:ELIElite Pharmaceuticals,
14/02/200815h00Business WireElite Pharmaceuticals, Inc. to Present Clinical Data at the American Academy of Pain Medicine's 24th Annual MeetingAMEX:ELIElite Pharmaceuticals,
31/01/200817h49Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Prospectus filed pursuant to Rule 424(b)(3) (424B3)AMEX:ELIElite Pharmaceuticals,
28/01/200812h00Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Notice of Effectiveness (EFFECT)AMEX:ELIElite Pharmaceuticals,
25/01/200812h01Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Statement of Ownership (SC 13G)AMEX:ELIElite Pharmaceuticals,
02/01/200823h28Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Securities Registration Statement (simplified form) (S-3/A)AMEX:ELIElite Pharmaceuticals,
13/11/200723h11Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ (Other) (8-K)AMEX:ELIElite Pharmaceuticals,
24/10/200722h46Edgar (US Regulatory)Elite Pharmaceuticals Inc /DE/ - Current report filingAMEX:ELIElite Pharmaceuticals,
18/07/200714h40Business WireElite Announces Closing of Series C Private PlacementAMEX:ELIElite Pharmaceuticals,
28/06/200723h42Business WireElite Pharmaceuticals Provides Update on Company's Progress and Projected MilestonesAMEX:ELIElite Pharmaceuticals,
 Showing the most relevant articles for your search:AMEX:ELI

Dernières Valeurs Consultées

EU
DG
Vinci
EU
HO
Thales
NYSE
MCD
McDonalds
EU
ACA
Credit Agricole
NYSE
DIS
Walt Disney
NYSE
KO
Coca Cola
EU
SGO
Cie de SaintGobain
EU
CS
Axa
NYSE
NKE
Nike
EU
RI
Pernod Ricard
SPI
SP500
S&P 500
EU
PX4
SBF 120
EU
VK
Vallourec
USI
USTECH100
US Tech 100
NASDAQ
MSFT
Microsoft
EU
LR
Legrand
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés